Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome

Tau 蛋白病和唐氏综合症的细胞和网络破坏及相关发病机制

基本信息

  • 批准号:
    10601035
  • 负责人:
  • 金额:
    $ 64.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-15 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

The goal of our studies is to better understand the mechanisms by which tau transmission and neuronal hyperexcitability drive the progression of neurodegeneration in Alzheimer's Disease (AD) Related Dementias (ADRD) that include Down Syndrome (DS) caused by trisomy of chromosome 21 (Ts21). Our studies are in line with the goals of RFA PAR-18-706 because we will focus on understanding “mechanisms underlying selective cell sensitivity to tau cell-to-cell spread in circuitry.” The foundation of our studies is that tau is a prime culprit in pathogenesis of ADRDs such as DS because tau is a major component of neurofibrillary tangles in DS brains and polymorphisms in the tau gene MAPT increase risk of AD and AD in Ts21 patients. Neuropathology in ADRD follows a temporal and spatial progression in brain, and there is growing evidence that the progressive neurodegeneration in ADRD is due to transsynaptic spread of tau via connected neurons. In addition to tau, neuronal hyperexcitability can occur at early stages of ADRD, and some have proposed that network dysfunction may be a driving force for neurodegeneration in ADRDs. We will investigate if altered neuronal activity due to overexpression of amyloid precursor protein (APP) caused by Ts21 contributes to the transsynaptic spread of tau, increasing the rate of neurodegeneration. We will use a multidisciplinary approach to study how APP overexpression found in ADRDs affects transmission of tau and impacts human brain circuitry. We will co-culture organoids and transplant human iPSC-derived cortical neurons from ADRD patients (tauP301L or Ts21) with control human cortical organoids or human fetal cortical slices and monitor the impact on neuronal circuits using a novel time lapse, imaging platform, four-dimensional robotic microscopy (4DRM). 4DRM will track functional properties of individual neurons in 4D in human primary brain slices over weeks, to give insight into how APP overexpression, hyperexcitability, and tau transmission interact to cause neurodegeneration. The ability to monitor neuronal circuitry in organoids and human brain slices longitudinally is innovative and critical in studying the slow degenerative processes that may be induced by tau transmission. We will use 4DRM in combination with multivariate Cox proportional hazards analysis to determine if network hyperexcitability and tau aggregation is detrimental, beneficial or inconsequential towards neuronal survival. To complement these in vitro studies, we developed an in vivo whole animal model of tauopathy in which transgenic zebrafish larvae overexpress human tauP301L in their nervous system and use 4DRM to monitor neuronal circuitry in the living animals. The GFP-tauP301L zebrafish model shows increased p-tau but no overt neuronal dysfunction, or neurodegeneration. When hyperexcitability is induced, the fish display sensitivity to neuronal death and behavioral signs of neurodegeneration. With this model, we will investigate the effect of hyperexcitability on aggregation of tau and mechanisms of tau transmission in vivo. By understanding mechanisms of tau transmission, we can develop strategies to block spread of neuropathology to slow the progression of AD.
我们的研究目的是更好地了解tau蛋白传递和神经元过度兴奋驱动阿尔茨海默病(AD)相关痴呆神经退行性变进展的机制 (ADRD),其包括由21号染色体三体(Ts 21)引起的唐氏综合征(DS)。我们的研究符合 与RFA PAR-18-706的目标一致,因为我们将专注于理解“电路中tau细胞间扩散的选择性细胞敏感性的潜在机制”。我们研究的基础是tau蛋白是ADRD(如DS)发病机制的罪魁祸首,因为tau蛋白是DS脑中神经元缠结的主要成分,tau基因MAPT多态性增加Ts 21患者AD和AD的风险。ADRD中的神经病理学遵循脑中的时间和空间进展,并且越来越多的证据表明ADRD中的进行性神经变性是由于tau经由连接的神经元的跨突触扩散。除tau蛋白外,神经元过度兴奋可发生在ADRD的早期阶段,有些人提出网络功能障碍可能是ADRD中神经变性的驱动力。我们将研究由于Ts 21引起的淀粉样前体蛋白(APP)过度表达而导致的神经元活性改变是否有助于tau的跨突触扩散,从而增加神经退行性变的速率。我们将使用多学科的方法来研究ADRD中发现的APP过表达如何影响tau的传递并影响人脑回路。我们将与对照人类皮质类器官或人类胎儿皮质切片共培养类器官,并移植来自ADRD患者(tauP 301 L或Ts 21)的人类iPSC衍生的皮质神经元,并使用新型时间推移、成像平台监测对神经元回路的影响四维机器人显微镜(4DRM)。4DRM将在数周内跟踪人类初级脑切片中4D个体神经元的功能特性,以深入了解APP过度表达,过度兴奋和tau蛋白传递如何相互作用导致神经退行性变。纵向监测类器官和人脑切片中神经元回路的能力在研究可能由tau蛋白传递诱导的缓慢退行性过程中具有创新性和关键性。我们将使用4DRM结合多变量考克斯比例风险分析,以确定网络过度兴奋和tau聚集对神经元存活是否有害、有益或无关紧要。为了补充这些体外研究,我们开发了一种tau蛋白病的体内整体动物模型,其中转基因斑马鱼幼虫在其神经系统中过表达人tauP 301 L,并使用4DRM来监测活体动物中的神经元回路。GFP-tauP 301 L斑马鱼模型显示p-tau增加,但没有明显的神经元功能障碍或神经变性。当过度兴奋被诱导时,鱼显示出对神经元死亡和神经变性的行为迹象的敏感性。利用该模型,我们将研究过度兴奋对tau蛋白聚集的影响, Tau在体内的传递机制。通过了解tau蛋白的传递机制,我们可以制定策略来阻止神经病理学的传播,以减缓AD的进展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN M FINKBEINER其他文献

STEVEN M FINKBEINER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN M FINKBEINER', 18)}}的其他基金

Image Tools for Computational Cellular Barcoding and Automated Annotation
用于计算细胞条形码和自动注释的图像工具
  • 批准号:
    10552638
  • 财政年份:
    2022
  • 资助金额:
    $ 64.14万
  • 项目类别:
Image Tools for Computational Cellular Barcoding and Automated Annotation
用于计算细胞条形码和自动注释的图像工具
  • 批准号:
    10367874
  • 财政年份:
    2022
  • 资助金额:
    $ 64.14万
  • 项目类别:
Role of central and peripheral immune crosstalk in FTD-Grn neurodegeneration
中枢和外周免疫串扰在 FTD-Grn 神经变性中的作用
  • 批准号:
    10514263
  • 财政年份:
    2022
  • 资助金额:
    $ 64.14万
  • 项目类别:
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
Tau 蛋白病和唐氏综合症的细胞和网络破坏及相关发病机制
  • 批准号:
    9974319
  • 财政年份:
    2020
  • 资助金额:
    $ 64.14万
  • 项目类别:
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
Tau 蛋白病和唐氏综合症的细胞和网络破坏及相关发病机制
  • 批准号:
    10377486
  • 财政年份:
    2020
  • 资助金额:
    $ 64.14万
  • 项目类别:
Cell and Network Disruptions and Associated Pathogenenesis in Tauopathy and Down Syndrome
Tau 蛋白病和唐氏综合症的细胞和网络破坏及相关发病机制
  • 批准号:
    10599756
  • 财政年份:
    2020
  • 资助金额:
    $ 64.14万
  • 项目类别:
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease
了解导致阿尔茨海默病神经精神症状的分子机制
  • 批准号:
    10406707
  • 财政年份:
    2019
  • 资助金额:
    $ 64.14万
  • 项目类别:
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease
了解导致阿尔茨海默病神经精神症状的分子机制
  • 批准号:
    10651757
  • 财政年份:
    2019
  • 资助金额:
    $ 64.14万
  • 项目类别:
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease
了解导致阿尔茨海默病神经精神症状的分子机制
  • 批准号:
    10439255
  • 财政年份:
    2019
  • 资助金额:
    $ 64.14万
  • 项目类别:
Understanding the molecular mechanisms that contribute to neuropsychiatric symptoms in Alzheimer Disease
了解导致阿尔茨海默病神经精神症状的分子机制
  • 批准号:
    10450771
  • 财政年份:
    2019
  • 资助金额:
    $ 64.14万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 64.14万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了